Cytodyn Inc (CYDY)

[jimmy667]

I believe there is a good probability that FDA grants an EUA within a month and that the CD16 and CD17 will be used to expand and focus the use of LL in Covid and possible full approval after these or further studies. What is needed is the knowledge of how best to use the drug and which patients respond the best. With more knowledge of how to dose for instance four shots, using with Dexamethasone ect. the efficacy will likely increase further. Advancing the protocols for the best patient outcomes. There is much to know still. CD10 and CD12 were early trials. The beginning studies not not the final studies. Most other drugs failed and were scrapped. Leronlimab is just getting started and continues to advance.